By now, you’ve likely come across the term “pure blood” in reference to people who have not received a COVID-19 mRNA transfection. If not in the wild, then perhaps in the occasional news headline coming out in objection to the term.
While the term itself is divisive and historically problematic, the underlying premise is understandable and straightforward. But for those who aren’t yet sold, allow me a brief summary.
In late 2020, a range of experimental gene therapy products were rolled out across the planet under the banner of “COVID-19 vaccines,” after an unprecedented “warp speed” development sprint. Despite the frequent assurances provided to them by the pharmaceutical companies and health authorities, many millions of people chose not to undergo this particular medical procedure. Each person has their own reasons, and the choice to decline unwanted medicine is in line with universal principles of informed consent and bodily autonomy.
Microjourneys is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
A few months ago, a story went viral about a family in New Zealand whose baby required a blood transfusion as part of invasive heart surgery.1 The six-month old child suffered from a congenital heart defect, and the prognosis without surgery was not good. However, his parents were concerned that the blood he would be given could contain components of the mRNA COVID-19 vaccine products circulating in the bodies of the blood donors at the time of their donation, or fragments of the SARS-CoV-2 spike protein which the shots are designed to produce in the body’s own cells.
Te Whatu Ora Health New Zealand rejected the family’s requests to use only “unvaccinated” blood. Their reasoning was that the New Zealand Blood Service “does not make a distinction between donations from those vaccinated or unvaccinated against COVID, as there is no extra risk from using vaccinated blood.”
NZ Blood’s FAQ page for COVID-19 vaccines and blood donation has been removed from the internet. An archived version reveals that the agency was telling donors as recently as November 2022 that “the spike protein is present in vanishingly small quantities in the blood in some people for the first two weeks after their mRNA vaccine. The chance of finding spike protein in donated blood is very small, and it will be in the picogram range if it is there at all. It is not found in the blood after this time period has passed.” They conclusively asserted that “there is no evidence that this represents any risk to recipients.”2
The American Red Cross took an even more absolute position in a September 13, 2022 post on Twitter, saying “[w]e don't label blood products as containing vaccinated or unvaccinated blood as the COVID-19 vaccine does not enter the bloodstream & poses no safety risks to the recipient.”3
Disturbingly, the American Red Cross was way off. As has been thoroughly and repeatedly summarized by Ryan Cristián of
, the contents of the vaccine vials as well as the resulting spike proteins have long been known to enter the bloodstream, both as a matter of design and by accident.
Pfizer’s own biodistribution studies on their candidate, BNT162b2 (the initial formulation rolled out by Pfizer-BioNTech in 2020-2022), describe the “LNPs [lipid nanoparticles] entering the blood stream,” resulting in the delivery of the vaccine payload to the liver of lab mice where the target protein was produced.4 These findings have replicated in humans multiple times over,5 with one study admitting that “the biodistribution, quantity, and persistence of vaccine mRNA and spike antigen after vaccination” remain “incompletely understood.”6 But by July 2022, there existed plenty of clinical and real-world evidence demonstrating that the vaccine components “remain in circulation for extended periods of time, retaining their ability to induce [spike protein] expression in contacted cells.”7
A study published in September 2022 found that circulating spike protein is associated with a wide range of long-term symptoms broadly diagnosed as COVID-19.8
It is safe to say that there exists more than enough evidence to justify an individual’s hesitations around them or their loved ones receiving a blood transfusion from an unspecific donor, whether or not you personally agree with their decision.
Parallel structures
So what does one do when faced with a challenge like that of the New Zealand family?
If the last few years have taught us anything, it is the importance of erecting parallel structures in order to protect against over-centralized systems such as food production, finance and healthcare.
Rather than relying on Walmart or Costco to perpetually keep their shelves stocked in the midst of an ongoing supply chain crisis,9 one can turn to their local farmers market, or work directly with independent farms.10 As governments and institutional banks across the Western world “de-bank” more and more people based solely on their political views,1112 lawful exercise of civil rights,13 and national origin,14 one can diversify their finances through Bitcoin or other “privacy” blockchains — or just use cash whenever possible.15
But what about addressing the much closer-to-the-heart issue of healthcare, bodily autonomy and medical privacy? Needless to say, there are plenty of industrious folks out there who have jumped at the opportunity to fill the gap.
Of course, the incident in New Zealand is just one of many in which people are being forced to accept transfusions from a single source. Many countries seem to have their bloodbanks centralized and hooked in with the healthcare system at large, such is the case with Canada and its Canadian Blood Services (CBS). Despite officially operating “at arm’s length from government,”16 CBS describes itself as “the country’s blood authority in all provinces and territories except Quebec.”17
Understandably, a number of “unvaccinated bloodbanks” have been set up to fill the void. And on first glance, many such organizations present as well-intentioned and well-run programs! But upon closer analysis, one can begin to identify red flags that suggest the solution may not be better than the problem being solved. Let’s take a look at a case study to explore this idea further.
Pure Blood Registry is a limited liability company based in Sanford, Florida.18 According to its website, the company offers “safe blood for emergencies & planned medical procedures.”19 It is a membership-based organization, offering a $500 Diamond/lifetime tier or a $120 “Donor & Recipient Member” tier which must be renewed annually. Conveniently, those who only wish to donate blood can do so at no cost!20
In a disclaimer at the bottom of its homepage, Pure Blood Registry clarifies that it “operates as a registry of individuals and facilitates connections between them,” and does “not provide medical advice or recommendations.”
In other words, the business involves taking in applications from people around the world who self-identify as being of “pure blood” (unvaccinated), the results of which are compiled into a registry of said individuals. Those who buy in are then granted access to this registry, allowing them to make contact with an appropriate blood donor in the event of an emergency, or while planning an upcoming medical procedure.
There’s one caveat, though. As explained in the fine print, “individuals who do not possess an active subscription to our Premium or Diamond Memberships and find themselves in need of a donor list during an emergency will be kindly requested to make a donation of $1,500 to our platform.” Not that this would be much help, though, as the company notes that both of their paid memberships “include a 30-day waiting period” before members can request that donor list.
It may be that Pure Blood Registry has already done great work in helping those in crisis to access the blood they need at a crucial time, or even that I’m misreading their website.
With that out of the way, who is behind the noble venture, after all?
Pure Blood Registry was incorporated on August 30, 2022 by Gil Levy, who describes himself as “Founder & Patriot.” His biography describes him as “an accomplished entrepreneur and visionary,” who travelled from Israel to California at an early age and embraced the American Dream. He reportedly founded Pure Blood Registry “as a passion-project for his daughter,” inspired by his values as a silver and gold stacker, gardener and self-reliant individual, as well as his experience “witnessing events unfold during the 2020 election cycle.”
It is not clear to me why some of these details are included, other than to paint a picture of a dissident battling the system on multiple fronts that aren’t strictly related to each other — the 2020 election, for example, being a rather odd thing to mention in this context.
Levy founded another company in February 2017 called Framed Listings, through which he provides photography and videography services for real estate.2122 His listed clients include Airbnb, Amazon, Coldwell Banker, Cushman & Wakefield, and Vrbo.23 From his biography on Framed Listings’ website, we further learn that Levy is a semi-pro poker player, playing on the Word Poker Tour (WPT) and World Series of Poker (WSOP) circuits. Sweet!
But the real concern comes from Pure Blood Registry’s partners.
MyID
First and foremost, we have MyID. If that name sounds familiar, it’s for good reason.
MyID is an American medical services company based in Saint George, Utah. As described on its Pure Blood Registry partner page, MyID is a digital medical identity device in the form of a QR code on a wristband.24
Users upload various medical documents “such as insurance information, living wills, x-rays, and any other medical records,” which can then be shared with anybody the user desires. The company boasts that there are “3 access points to your data,” as opposed to their competitors who offer only a single access point.
More to that point, in the case of an emergency, a smartphone camera pointed at the QR code will reveal your “vital medical information” so first responders can help you, “even if you’re unable to answer questions yourself.”25
MyID is the latest iteration of a company that has undergone multiple rebrands. Steve Schone founded the company in November 2010 under the name LifeStrength.2627
LifeStrength sold “balance wristbands and energy bracelets” which used “the exclusive ION HEALTH technology process that uniquely aggregates the positive properties of seven minerals and gemstones into a performance enhancing and attractive balance bracelet.”28 MyID was introduced as a product sometime around 2012, with a very similar description to the one it has today.29
In August 2013, LifeStrength announced a name change to ENDEVR.30 MyID, LLC was incorporated as a separate company on February 20, 2018.31
MyID was very busy during the COVID-19 era.
In April 2020, MyID published several promotional videos for the Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test developed by Predictive Laboratories and distributed in partnership with Wellgistics.32
Results of the antibody test could be uploaded to the MyID app, which would provide that data to health authorities and the Centers for Disease Control and Prevention (CDC). The test and application were described as ways to help people return to work as they could provide “proof of immunity.”33
Later in 2020, MyID introduced the MyID COVID Cleared Program, which “enables individuals to voluntarily self-report symptoms/temperatures, order/receive COVID-19 related test results, and choose when and with whom to share those results, thereby putting employees in control of their sensitive data.”34
In January 2021, MyID announced a partnership with pharmaceutical giant Merck to “provide the MyID mobile app and wristband to patients” being treated with Merck's Keytruda, an antibody-based immunotherapy drug.35 This was now an explicit application of the MyID platform in the context of a clinical trial.
MyID also participated in the National Community Pharmacists Association (NCPA)'s 2021 Annual Convention,36 focused on how to “leverage the disruption of the pandemic, change the face of pharmacy, and power up our practices.”37 Event sponsors included McKesson, Merck, Moderna and Pfizer.38
UPDATE - August 25, 2023:I’m not sure how I missed this, but it turns out that Wellgistics also sponsored this event! See below logo wall as published here.
Who is Wellgistics, you may ask? Hold tight. We’ll get to that in just a few paragraphs.
This connection with some of the largest drug companies on the planet is certainly unexpected, given Pure Blood Registry’s ostensible role as a “dissident” and “alternative” organization as compared to these exact companies. Certainly, it seems their partner, MyID, has a different set of priorities much more aligned with institutional interests.
MyID hosts an informed consent page noting that part of their mission is to “advance research related to the study of human health.”39 Last updated February 15, 2021, the page describes the “MyID Human Diversity Project” (also called the MyID Study Project) which seeks to “develop new or improved diagnostic tools and therapies to treat diseases or other conditions.” While some of this research is said to be done by MyID employees, partners “might include academic institutions as well as non-profit and for-profit businesses or government agencies.” Strangely, the link provided to learn more about these collaborators leads to a website for AncestryDNA, describing the Ancestry Human Diversity Project.40
Reviewing MyID’s privacy policy reveals that as of October 2021, MyID offers users “access to COVID-19 immunization records,” in “partnership with public health agencies,” using “personal and sensitive data required directly to support COVID-19-related-efforts.”41
On May 12, 2020, MyID's general counsel, Douglas Edmunds, filed a trademark application for the MyID logo and the design of its wristbands, as well as the previous image of a so-called “Heath Passport” (their words, not mine). Matthew Starley, Chief Operating Officer at Wellgistics, was listed as a secondary contact.42 Recall that Wellgistics was one of MyID’s partners in the Assurance AB COVID-19 test.
Wellgistics is an American pharmaceutical distribution company based in Lakeland, Florida. As it turns out, Edmunds serves as general counsel for both MyID and Wellgistics.43Brian Norton, CEO of Wellgistics,44 is also named as Chairman of MyID’s Board of Directors in the Merck partnership announcement.
Why is this notable? Well, Wellgistics is partnered with a number of pharmaceutical companies in its commercial activities, the most egregious of which is none other than Pfizer.45
Another company of interest is Rising Pharmaceuticals, which provided the hydroxychloroquine for the first randomized control trial (RCT) evaluating its use in treating COVID-19.46 This was the trial led by David Boulware,47 with funding from Steve Kirsch, Roblox founder David Baszucki and two Chinese-American community organizations.48
On April 1, 2020, Wellgistics entered an agreement with yet another previously-mentioned partner, Predictive Laboratories, to purchase a minimum of 1,000,000 units of the aforementioned Assurance AB COVID-19 IgM/IgG Rapid Antibody Test.49
This is where the rabbit hole of biometric data harvesting gets real deep.
Predictive Laboratories was, until very recently, an American clinical research company based in Salt Lake City, Utah. According to its now non-existent website, Predictive Laboratories focused on “clinical and discovery work for human infertility and genetic conditions affecting women and children.” Its laboratory facility was “active in new test and technology development” and collaborated with “numerous federal, state, and local agencies, universities, commercial laboratories, and private clients.” It was incorporated June 2, 2017 as a subsidiary of a larger company called Predictive Technology Group.50
Predictive Technology Group has a colourful history of its own, much of which is laid out in this excellent analysis by Hindenburg Investment Research, published in July 2019 by Seeking Alpha. The company was originally founded on August 25, 2005 under the name K-9 Concepts, Inc.5152 It was based in Kowloon, Hong Kong, and focused on marketing vitamin C-laced shower heads.53 In February 2008, the company performed a reverse merger with a shoe company called Aussie Soles.54 Rather than integrating its new subsidiary into its branding, K-9 Concepts changed its own name and continued operations as Aussie Soles Group, Inc. It purchased another company called Global Homes, Inc.on January 7, 2010,55 and once again rebranded to the Global Housing Group.
Finally, this company renamed to Global Enterprises Group. On March 24, 2015, the company announced that it had acquired a biotech startup called Predictive Therapeutics, LLC.56 Shortly after, they launched a shiny new website on May 4, 2015, seemingly with the sole purpose of publicizing the company’s new biotech direction.57 Soon after that, the company adopted Predictive’s name and branding and became Predictive Technology Group.
Predictive Therapeutics was itself founded in September 2013 by Bradley Robinson.5859 He also founded LifeCode Genetics, which the new Predictive Technology Group acquired in November 2015.60 This company changed its name to Predictive Diagnostics in June 2016.61
Further expansion of the Predictive portfolio came through what the Seeking Alpha article describes as an “acquisition spree.” Inception Dx was acquired in September 2018,62 merging with Predictive Laboratories as of April 2019 under the leadership of Inception Dx’s founder, Kenneth Ward.63 Ward also founded Taueret Laboratories in 2003,6465 from which Predictive purchased “key assets” in August 2018.66Juneau Biosciences — yet another company founded by Ward — has been slowly acquired over several years by Predictive, through shady mechanisms described at length in the Seeking Alpha article.
Its most recent acquisition was FlagshipHealth Group, whose website currently boasts their marketing of “all types of Covid-19 tests” including PCR and rapid antigen67 — both of which, it should be noted, are types of genetic tests.
Predictive Therapeutics acquired ReNovo Biotech in March 2016,68 repackaging it for relaunch the following month as Predictive Biotech.69 ReNovo’s Founder and CEO, Eric Olson, carried his position over into Predictive Biotech, where he remains today.70
But Mr. Olson holds another relevant position. At least as of January 2021, he was also CEO of MyID. This fact is revealed in the same Merck/MyID press release that listed Brian Norton as both CEO of Wellgistics and Chair of MyID’s board of directors. Recall as well that Wellgistics and MyID share Douglas Edmunds as their chief counsel.
In other words, there exists a strange and incestuous relationship between MyID, Wellgistics and Predictive Technology Group, each carrying with them their own sets of red flags and possible ulterior motives for the mass harvesting and analysis of biometric data.
MyID focuses on digital identification based on biometrics and private medical information; Wellgistics markets and distributes drugs and treatments for biotech companies including Pfizer; and Predictive Technology Group’s range of subsidiaries cover testing, analysis and treatment of disease based entirely around their (by some accounts) shoddy and unproven genetic technology.
Speaking of Pfizer, Predictive Technology Group’s staff includes several alumni from the company and its subsidiaries, including Chief Development Officer Bruce Forrest and Board Chair John Sorrentino.7172
Then there’s the just plain weird coincidences — who could forget MyID’s perfectly-timed rollout into East Palestine, Ohio mere weeks before the Norfolk Southern train derailment that is causing severe and ongoing health issues among its residents and neighbours on the Eastern Seaboard to this day?73747576
How is all of this any different than the solutions being pushed on humanity by our public health institutions and their friends in Big Pharma? And if we agree that it’s not really much of an alternative at all, then what in the world would the motivation be for Pure Blood Registry to partner with such a company as MyID? Could the affiliate royalties really be that good?
In any case, Pure Blood Registry strongly encourages its clients to purchase the premium MyID package.
Do you feel comfortable sharing your blood with this organization, with all of the above in mind?
Conclusion
Believe it or not, this article only covered one of Pure Blood Registry’s partners, of which there are now six. I have looked at the others and identified potential red flags with each, some of which I intend to explore in the near future.
But until then, I leave you with this: “It's not enough to be against something. You have to be for something better.”
This is a quote from Tony Stark that I thought I had read in a comic years ago, though it may have actually come from the Captain America: Civil War movie. Regardless, it has stuck with me ever since, and it is a piece of wisdom that I invite readers to contemplate in the days to come.
I, like many other average citizens of the world, am opposed to the kind of reality previewed during the COVID-19 era. One of the most egregious invasions of privacy and bodily autonomy over the last few years has been the use of private medical information and biometric data to determine whether one shall be granted permission to enjoy their God-given liberty, or be relegated to an artificial second class citizenship.
This entire premise was based around the misleading use of genetic tests, the samples from which wound up in the hands of government agencies and sold to private interests around the world. Then, after gene therapy-based vaccine products were mass-distributed globally, people were made to disclose whether or not they had opted to receive this genetic treatment in order to avoid being ejected from work, school and even family life.
It is the avoidance of this very set of “medical countermeasures” and surveillance that is leading so many millions of people to seek alternatives such as the one ostensibly offered by Pure Blood Registry. But in doing so, we run the risk of falling into a new version of same problem, hiding behind a more attractive mask. It’s not enough to be against one idea, and then fail to address the reasons why people don’t like the idea in the first place.
Permanent solutions take time, and what’s at stake is far too precious to get wrong by jumping into quick fixes without fully exploring the consequences.
And in my opinion, we’re not gonna get there if we continue to identify ourselves as more or less “pure” than our friends, family and community.
Thank you for reading, and I invite you to share your own perspective in the comments!
Microjourneys is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
American Red Cross [@RedCross]. (2022, September 14). “We don’t label blood products as containing vaccinated or unvaccinated blood as the COVID-19 vaccine does not enter the bloodstream & poses no safety risks to the recipient. If you have safety concerns about potential blood transfusions, please speak with your medical care team.” [Tweet]. Twitter. https://web.archive.org/web/20230214110356/https://twitter.com/RedCross/status/1569869268296105990
Ogata, A. F., Cheng, C.-A., Desjardins, M., Senussi, Y., Sherman, A. C., Powell, M., Novack, L., Von, S., Li, X., Baden, L. R., & Walt, D. R. (2021). Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients. Clinical Infectious Diseases, 74(4), 715–718. https://doi.org/10.1093/cid/ciab465
Röltgen, K., Nielsen, S. C. A., Silva, O., Younes, S. F., Zaslavsky, M., Costales, C., Yang, F., Wirz, O. F., Solis, D., Hoh, R. A., Wang, A., Arunachalam, P. S., Colburg, D., Zhao, S., Haraguchi, E., Lee, A. S., Shah, M. M., Manohar, M., Chang, I., & Gao, F. (2022). Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell, 185(6), 1025-1040.e14. https://doi.org/10.1016/j.cell.2022.01.018
Fertig, T. E., Chitoiu, L., Marta, D. S., Ionescu, V.-S., Cismasiu, V. B., Radu, E., Angheluta, G., Dobre, M., Serbanescu, A., Hinescu, M. E., & Gherghiceanu, M. (2022). Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination. Biomedicines, 10(7), 1538. https://doi.org/10.3390/biomedicines10071538
Meet Our Team. Framed Listings Real Estate, Hotel & Commercial Photography and Video Solutions. Retrieved August 4, 2023, from https://www.framedlistings.com/meetourteam
Gotta call you out for misrepresentations these are not micro-journeys they are fact heavy deep dives with enormous research effort behind it.. you're overly modest so that's on record now! <3
As a family of hemophiliacs my introduction to toxic activity of Red Cross began w AIDS tainted blood products that infected countless Americans but was exported to Canada & abroad once testing rules made it unsalable in USA. Given their indifference to human health it should be little surprise they originate with the same cabal behind Eugenics and CIA.. amazing how the same hands are in every pie, eh? This is a good intro to Red Cross history w is USAID style activity.
Gotta call you out for misrepresentations these are not micro-journeys they are fact heavy deep dives with enormous research effort behind it.. you're overly modest so that's on record now! <3
As a family of hemophiliacs my introduction to toxic activity of Red Cross began w AIDS tainted blood products that infected countless Americans but was exported to Canada & abroad once testing rules made it unsalable in USA. Given their indifference to human health it should be little surprise they originate with the same cabal behind Eugenics and CIA.. amazing how the same hands are in every pie, eh? This is a good intro to Red Cross history w is USAID style activity.
https://web.archive.org/web/20020306074217/http://reformed-theology.org/html/books/bolshevik_revolution/chapter_05.htm
Excellent research as always, Liam. Keep up the good work!